Concepedia

Anna Vuorinen

AV

Statistics

Publications

23

Citations

1.1K

H-Index

18

Active since

2011

Affiliations

Universität Innsbruck(Current)

University of Basel

DSM (Switzerland)

Bristol-Myers Squibb (United States)

GlaxoSmithKline (United Kingdom)

Anna Vuorinen is an author at Universität Innsbruck specializing in pharmacology, 11 beta-hydroxysteroid dehydrogenase, and pharmacy.

Publications per year

2011–2020

23

Publications

23

In silico toxicology protocols

Glenn J. Myatt, Ernst Ahlberg, Yumi Akahori et al. · Regulatory Toxicology and Pharmacology · 2018 · 241 citations · Full text

, , +11

Honokiol: A non-adipogenic PPARγ agonist from nature

Atanas G. Atanasov, Jian N. Wang, Shi P. Gu et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2013 · 130 citations · Full text

, , +13

Genetic toxicology in silico protocol

Catrin Hasselgren, Ernst Ahlberg, Yumi Akahori et al. · Regulatory Toxicology and Pharmacology · 2019 · 82 citations · Full text

, , +13

Interference of Paraben Compounds with Estrogen Metabolism by Inhibition of 17β-Hydroxysteroid Dehydrogenases

Roger T. Engeli, Simona R. Rohrer, Anna Vuorinen et al. · International Journal of Molecular Sciences · 2017 · 78 citations · Full text

, , +15

Ligand-Based Pharmacophore Modeling and Virtual Screening for the Discovery of Novel 17β-Hydroxysteroid Dehydrogenase 2 Inhibitors

Anna Vuorinen, Roger T. Engeli, Arne Meyer et al. · Journal of Medicinal Chemistry · 2014 · 74 citations · Full text

, , +17

1–5 of 23